Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2013

01-01-2013 | Article

Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance

Authors: F. Dusemund, B. Bucher, S. Meyer, R. Thomann, F. Kühn, S. Bassetti, M. Sprenger, E. Baechli, T. Sigrist, M. Schwietert, D. Amin, P. Hausfater, E. Carre, P. Schuetz, J. Gaillat, K. Regez, R. Bossart, U. Schild, B. Müller, W. C. Albrich, For the ProREAL study team

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Procalcitonin (PCT)-guided antibiotic stewardship is a successful strategy to decrease antibiotic use. We assessed if clinical judgement affected compliance with a PCT-algorithm for antibiotic prescribing in a multicenter surveillance of patients with lower respiratory tract infections (LRTI).
Initiation and duration of antibiotic therapy, adherence to a PCT algorithm and outcome were monitored in consecutive adults with LRTI who were enrolled in a prospective observational quality control. We correlated initial clinical judgment of the treating physician with algorithm compliance and assessed the influence of PCT on the final decision to initiate antibiotic therapy.
PCT levels correlated with physicians’ estimates of the likelihood of bacterial infection (p for trend <0.02). PCT influenced the post-test probability of antibiotic initiation with a greater effect in patients with non-pneumonia LRTI (e.g., for bronchitis: −23 % if PCT ≤ 0.25 μg/L and +31 % if PCT > 0.25 μg/L), in European centers (e.g., in France −22 % if PCT ≤ 0.25 μg/L and +13 % if PCT > 0.25 μg/L) and in centers, which had previous experience with the PCT-algorithm (−16 % if PCT ≤ 0.25 μg/L and +19 % if PCT > 0.25 μg/L). Algorithm non-compliance, i.e. antibiotic prescribing despite low PCT-levels, was independently predicted by the likelihood of a bacterial infection as judged by the treating physician. Compliance was significantly associated with identification of a bacterial etiology (p = 0.01).
Compliance with PCT-guided antibiotic stewardship was affected by geographically and culturally-influenced subjective clinical judgment. Initiation of antibiotic therapy was altered by PCT levels. Differential compliance with antibiotic stewardship efforts contributes to geographical differences in antibiotic prescribing habits and potentially influences antibiotic resistance rates.
Literature
1.
go back to reference Grill MF, Maganti RK (2011) Neurotoxic effects associated with antibiotic use: management considerations. BJCP 72(3):381–93 Grill MF, Maganti RK (2011) Neurotoxic effects associated with antibiotic use: management considerations. BJCP 72(3):381–93
2.
go back to reference Stewardson AJ, Huttner B, Harbarth S (2011) At least it won’t hurt: the personal risks of antibiotic exposure. Curr Opin Pharmacol 11(5):446–52PubMedCrossRef Stewardson AJ, Huttner B, Harbarth S (2011) At least it won’t hurt: the personal risks of antibiotic exposure. Curr Opin Pharmacol 11(5):446–52PubMedCrossRef
3.
go back to reference Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E (2011) Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. CID 53(1):42–8CrossRef Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E (2011) Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. CID 53(1):42–8CrossRef
4.
go back to reference Harbarth S, Emonet S (2006) Navigating the World Wide Web in search of resources on antimicrobial resistance. CID 43(1):72–8CrossRef Harbarth S, Emonet S (2006) Navigating the World Wide Web in search of resources on antimicrobial resistance. CID 43(1):72–8CrossRef
5.
go back to reference Van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H et al (2008) Antimicrobial drug use and resistance in Europe. EID 14(11):1722–30 Van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H et al (2008) Antimicrobial drug use and resistance in Europe. EID 14(11):1722–30
6.
go back to reference Albrich WC, Monnet DL, Harbarth S (2004) Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. EID 10(3):514–517 Albrich WC, Monnet DL, Harbarth S (2004) Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. EID 10(3):514–517
7.
go back to reference Dagan R, Barkai G, Givon-Lavi N, Sharf AZ, Vardy D, Cohen T et al (2008) Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? JID 197(8):1094–1102PubMedCrossRef Dagan R, Barkai G, Givon-Lavi N, Sharf AZ, Vardy D, Cohen T et al (2008) Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? JID 197(8):1094–1102PubMedCrossRef
8.
go back to reference Nasrin D, Collignon PJ, Roberts L, Wilson EJ, Pilotto LS, Douglas RM (2002) Effect of beta lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. BMJ 324(7328):28–30PubMedCrossRef Nasrin D, Collignon PJ, Roberts L, Wilson EJ, Pilotto LS, Douglas RM (2002) Effect of beta lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. BMJ 324(7328):28–30PubMedCrossRef
9.
go back to reference Carmeli Y, Troillet N, Karchmer AW, Samore MH (1999) Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Int Med 159(10):1127–1132CrossRef Carmeli Y, Troillet N, Karchmer AW, Samore MH (1999) Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Int Med 159(10):1127–1132CrossRef
10.
go back to reference Cosgrove SE, Carmeli Y (2003) The impact of antimicrobial resistance on health and economic outcomes. CID 36(11):1433–1437CrossRef Cosgrove SE, Carmeli Y (2003) The impact of antimicrobial resistance on health and economic outcomes. CID 36(11):1433–1437CrossRef
11.
go back to reference Cosgrove SE (2006) The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. CID 42(Suppl 2):S82–89CrossRef Cosgrove SE (2006) The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. CID 42(Suppl 2):S82–89CrossRef
12.
go back to reference Spellberg B (2011) The antibiotic crisis: can we reverse 65 years of failed stewardship? Arch Int Med 171(12):1080–1081CrossRef Spellberg B (2011) The antibiotic crisis: can we reverse 65 years of failed stewardship? Arch Int Med 171(12):1080–1081CrossRef
13.
go back to reference Cars O, Molstad S, Melander A (2001) Variation in antibiotic use in the European Union. Lancet 357(9271):1851–1853PubMedCrossRef Cars O, Molstad S, Melander A (2001) Variation in antibiotic use in the European Union. Lancet 357(9271):1851–1853PubMedCrossRef
14.
go back to reference Harbarth S, Albrich W, Goldmann DA, Huebner J (2001) Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis 1(4):251–261PubMedCrossRef Harbarth S, Albrich W, Goldmann DA, Huebner J (2001) Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis 1(4):251–261PubMedCrossRef
15.
go back to reference Finch RG, Metlay JP, Davey PG, Baker LJ, International Forum on Antibiotic Resistance (2002) Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 4(1):44–53 Finch RG, Metlay JP, Davey PG, Baker LJ, International Forum on Antibiotic Resistance (2002) Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 4(1):44–53
16.
go back to reference Hulscher ME, Grol RP, van der Meer JW (2010) Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 10(3):167–175PubMedCrossRef Hulscher ME, Grol RP, van der Meer JW (2010) Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 10(3):167–175PubMedCrossRef
17.
go back to reference Harbarth S, Albrich W, Brun-Buisson C (2002) Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. EID 8(12):1460–1467 Harbarth S, Albrich W, Brun-Buisson C (2002) Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. EID 8(12):1460–1467
18.
go back to reference Filippini M, Masiero G, Moschetti K (2006) Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Healthpol 78(1):77–92 Filippini M, Masiero G, Moschetti K (2006) Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Healthpol 78(1):77–92
19.
go back to reference Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M et al (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363(9409) Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M et al (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363(9409)
20.
go back to reference Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR et al (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. AJRCCM 174(1):84–93 Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR et al (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. AJRCCM 174(1):84–93
21.
go back to reference Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I et al (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302(10):1059–1066PubMedCrossRef Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I et al (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302(10):1059–1066PubMedCrossRef
22.
go back to reference Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C et al (2010) Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375(9713):463–474PubMedCrossRef Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C et al (2010) Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375(9713):463–474PubMedCrossRef
23.
go back to reference Schuetz P, Batschwaroff M, Dusemund F, Albrich W, Burgi U, Maurer M et al (2010) Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. EJCMID 29(3):269–277CrossRef Schuetz P, Batschwaroff M, Dusemund F, Albrich W, Burgi U, Maurer M et al (2010) Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. EJCMID 29(3):269–277CrossRef
24.
go back to reference Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B (2010) Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 8(5):575–587PubMedCrossRef Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B (2010) Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 8(5):575–587PubMedCrossRef
25.
go back to reference Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kuehn F, Bassetti S, Sprenger M, Bachli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Gaillat J, Schuetz P, Regez K, Bossart R, Schild U, Mueller B (2012) Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life” - an international, multicenter poststudy survey (ProREAL). Arch Int Med 172(9):715–722CrossRef Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kuehn F, Bassetti S, Sprenger M, Bachli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Gaillat J, Schuetz P, Regez K, Bossart R, Schild U, Mueller B (2012) Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in “real life” - an international, multicenter poststudy survey (ProREAL). Arch Int Med 172(9):715–722CrossRef
26.
go back to reference Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C et al (2007) Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res 7:102PubMedCrossRef Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C et al (2007) Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res 7:102PubMedCrossRef
27.
go back to reference Fischer JE, Harbarth S, Agthe AG, Benn A, Ringer SA, Goldmann DA et al (2004) Quantifying uncertainty: physicians’ estimates of infection in critically ill neonates and children. CID 38(10):1383–1390CrossRef Fischer JE, Harbarth S, Agthe AG, Benn A, Ringer SA, Goldmann DA et al (2004) Quantifying uncertainty: physicians’ estimates of infection in critically ill neonates and children. CID 38(10):1383–1390CrossRef
28.
go back to reference Bartlett JG (2011) Diagnostic tests for agents of community-acquired pneumonia. CID 52(S4):296–304CrossRef Bartlett JG (2011) Diagnostic tests for agents of community-acquired pneumonia. CID 52(S4):296–304CrossRef
29.
go back to reference Schwartz A (2011) Medical decision making and medical education: challenges and opportunities. Perspect Biol Med 54(1):68–74PubMedCrossRef Schwartz A (2011) Medical decision making and medical education: challenges and opportunities. Perspect Biol Med 54(1):68–74PubMedCrossRef
30.
go back to reference Gonzales R, Sande MA (2000) Uncomplicated acute bronchitis. Ann Int Med 133(12):981–991PubMed Gonzales R, Sande MA (2000) Uncomplicated acute bronchitis. Ann Int Med 133(12):981–991PubMed
31.
go back to reference Gonzales R, Steiner JF, Sande MA (1997) Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 278(11):901–904PubMedCrossRef Gonzales R, Steiner JF, Sande MA (1997) Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 278(11):901–904PubMedCrossRef
32.
33.
go back to reference Sabuncu E, David J, Bernede-Bauduin C, Pepin S, Leroy M, Boelle PY et al (2009) Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002–2007. PLoS Medicine 6(6):e1000084PubMedCrossRef Sabuncu E, David J, Bernede-Bauduin C, Pepin S, Leroy M, Boelle PY et al (2009) Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002–2007. PLoS Medicine 6(6):e1000084PubMedCrossRef
34.
go back to reference Huttner B, Goossens H, Verheij T et al (2010) Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. The Lancet ID 10(1):17–31CrossRef Huttner B, Goossens H, Verheij T et al (2010) Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. The Lancet ID 10(1):17–31CrossRef
35.
go back to reference Aujesky D, McCausland JB, Whittle J, Obrosky DS, Yealy DM, Fine MJ (2009) Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia. CID 49(10):e100–108CrossRef Aujesky D, McCausland JB, Whittle J, Obrosky DS, Yealy DM, Fine MJ (2009) Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia. CID 49(10):e100–108CrossRef
36.
go back to reference Grol R, Grimshaw J (1999) Evidence-based implementation of evidence-based medicine. Joint Comm J Qual Im 25(10):503–513 Grol R, Grimshaw J (1999) Evidence-based implementation of evidence-based medicine. Joint Comm J Qual Im 25(10):503–513
37.
go back to reference Hannes K, Leys M, Vermeire E, Aertgeerts B, Buntinx F, Depoorter AM (2005) Implementing evidence-based medicine in general practice: a focus group based study. BMC Fam Pract 6:37PubMedCrossRef Hannes K, Leys M, Vermeire E, Aertgeerts B, Buntinx F, Depoorter AM (2005) Implementing evidence-based medicine in general practice: a focus group based study. BMC Fam Pract 6:37PubMedCrossRef
38.
go back to reference Kitto S, Petrovic A, Gruen RL, Smith JA (2011) Evidence-based medicine training and implementation in surgery: the role of surgical cultures. JECP 17(4):819 Kitto S, Petrovic A, Gruen RL, Smith JA (2011) Evidence-based medicine training and implementation in surgery: the role of surgical cultures. JECP 17(4):819
39.
go back to reference Haspel RL (2010) Implementation and assessment of a resident curriculum in evidence-based transfusion medicine. Arch Pathol Lab Med 134(7):1054–1059PubMed Haspel RL (2010) Implementation and assessment of a resident curriculum in evidence-based transfusion medicine. Arch Pathol Lab Med 134(7):1054–1059PubMed
Metadata
Title
Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance
Authors
F. Dusemund
B. Bucher
S. Meyer
R. Thomann
F. Kühn
S. Bassetti
M. Sprenger
E. Baechli
T. Sigrist
M. Schwietert
D. Amin
P. Hausfater
E. Carre
P. Schuetz
J. Gaillat
K. Regez
R. Bossart
U. Schild
B. Müller
W. C. Albrich
For the ProREAL study team
Publication date
01-01-2013
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2013
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1713-8

Other articles of this Issue 1/2013

European Journal of Clinical Microbiology & Infectious Diseases 1/2013 Go to the issue